| |
Publications
2015
| Title |
Itolizumab in combination with methotrexate
modulates active rheumatoid arthritis: safety
and efficacy from a phase 2, randomized,
open-label, parallel-group, dose-ranging
study.
|
| Authors |
Arvind Chopra, S. Chandrashekara,
Rajgopalan Iyer, Liza Rajasekhar, Naresh
Shetty, Sarathchandra Mouli Veeravalli,
Alakendu Ghosh, Mrugank Merchant, Jyotsna
Oak, Vikram Londhey, Abhijit Barve, M. S.
Ramakrishnan, and Enrique Montero |
| Journal |
Clinical Rheumatology 2015 Jun 7. Epub. |
| Title |
Long-term efficacy and safety of itolizumab in
patients with moderate-to-severe chronic
plaque psoriasis: A double-blind, randomized
withdrawal, placebo-controlled study. |
| Authors |
Sunil Dogra, Krupashankar D. S., Leelavathy Budamakuntla, C. R. Srinivas, Uday Khopkar,
Sandesh Gupta, Narendra Shetty, Dasiga
Venkata Subrahmanya Pratap, M. G. Gopal,
T. Narayana Rao, Vijay Garg, T. K. Sumathy,
Abir Saraswat, Ramesh Bhat, Mahendra Kura,
Neeraj Pandey, Radha Shah, Kotla Sai
Krishna, Dalavai Padmaja, G. Manmohan,
Ramakrishnan M.S., Abhijit Barve, and
Enrique Montero |
| Journal |
Journal of the American Academy of
Dermatology 2015; 73:331-333 |
| Title |
Itolizumab provides sustained remission in plaque psoriasis: a 5-year follow-up
experience |
| Authors |
L. Budamakuntla, M. Madaiah, S.
Sarvajnamurthy and S. Kapanigowda** |
| Journal |
Clinical and Experimental Dermatology 2015;
40:152-5. |
**Biocon personnel provided expert review and editorial assistance
| Title |
Enhancement in production of recombinant two-chain Insulin Glargine by over-expression
of Kex2 protease in Pichia pastoris. |
| Authors |
Suma Sreenivas, Sateesh M. Krishnaiah,
Nagaraja Govindappa, Yogesh Basavaraju,
Komal Kanojia, Niveditha Mallikarjun,
Jayaprakash Natarajan, Amarnath Chatterjee
and Kedarnath N. Sastry |
| Journal |
Applied Microbiology and Biotechnology 2015;
99:327–336. |
|
|
